$2.88 -0.04 (-1.37%) Rigel Pharmaceuticals Inc - NASDAQ

Apr. 28, 2016 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 2.88
Trade Time: Apr 28 04:00 PM Eastern Daylight Time
Change: -0.04 (-1.37%)
Prev Close: 2.92
Open: 2.94
Bid: 2.88
Ask: 2.89

Competitors

Ticker Name Volume % Change
BMY Bristol-Myers Squibb Co 13.65M +2.89%
CELG Celgene Corp 8.60M +1.77%
AZN AstraZeneca Shs Sponsored American Deposit Share Repr 1/2 Sh 3.70M -0.51%
IRWD Ironwood Pharmaceuticals Inc 3.04M +3.24%
INVA Innoviva Inc 827.40K -0.96%

RIGL Stock Analysis

  1. No results found.

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 07:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST